| Line item | 2025-05-31 FY | 2024-05-31 FY | 2023-12-31 FY | 2023-05-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-01-31 FY |
|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – | – |
| SG&A | $39.86K | $30.86K | $28.92K | $8.88K | $39.73K | $17.33K | $34.69K |
| Operating Income | -$39.86K | -$30.86K | -$28.92K | – | -$39.73K | -$17.33K | – |
| Interest Expense | – | – | $364.00 | $364.00 | $592.00 | – | – |
| Tax Expense | – | – | – | – | – | – | – |
| Net Income | -$39.86K | -$30.86K | -$29.28K | -$8.88K | -$40.33K | -$17.33K | -$34.69K |
| EPS (basic) | -0.5400 | -0.4200 | -0.4000 | -0.1200 | -0.5500 | -0.2400 | -0.4700 |
| EPS (diluted) | -0.5400 | -0.4200 | -0.4000 | -0.1200 | -0.5500 | – | – |
| Shares (diluted) | $73.20K | $73.20K | $73.20K | $73.20K | $73.20K | – | – |